SPDR S&P Biotech ETF (NYSEARCA:XBI) Stake Lowered by Ted Buchan & Co

Ted Buchan & Co lessened its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.5% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 85,231 shares of the exchange traded fund’s stock after selling 4,977 shares during the quarter. SPDR S&P Biotech ETF comprises about 3.6% of Ted Buchan & Co’s investment portfolio, making the stock its 10th biggest holding. Ted Buchan & Co’s holdings in SPDR S&P Biotech ETF were worth $7,675,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in XBI. Proficio Capital Partners LLC grew its holdings in shares of SPDR S&P Biotech ETF by 16,156.1% in the fourth quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock valued at $82,615,000 after purchasing an additional 911,686 shares in the last quarter. Raymond James Financial Inc. bought a new position in SPDR S&P Biotech ETF during the fourth quarter valued at $55,529,000. Mirae Asset Securities USA Inc. grew its stake in shares of SPDR S&P Biotech ETF by 66.7% in the 4th quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock worth $135,090,000 after buying an additional 600,000 shares in the last quarter. J.Safra Asset Management Corp increased its holdings in shares of SPDR S&P Biotech ETF by 461.6% in the 4th quarter. J.Safra Asset Management Corp now owns 292,502 shares of the exchange traded fund’s stock worth $26,293,000 after buying an additional 240,415 shares during the last quarter. Finally, Clearbridge Investments LLC raised its position in shares of SPDR S&P Biotech ETF by 20.5% during the 4th quarter. Clearbridge Investments LLC now owns 571,664 shares of the exchange traded fund’s stock valued at $51,484,000 after buying an additional 97,401 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 5.7 %

XBI opened at $73.66 on Friday. The stock has a 50-day moving average of $88.13 and a 200 day moving average of $93.23. SPDR S&P Biotech ETF has a 12 month low of $73.25 and a 12 month high of $105.47. The firm has a market cap of $4.65 billion, a P/E ratio of 11.47 and a beta of 1.00.

SPDR S&P Biotech ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were issued a $0.0053 dividend. The ex-dividend date was Monday, March 24th.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.